List of Atorvaliq drug patents

Atorvaliq is owned by Cmp Dev Llc.

Atorvaliq contains Atorvastatin Calcium.

Atorvaliq has a total of 1 drug patent out of which 0 drug patents have expired.

Atorvaliq was authorised for market use on 01 February, 2023.

Atorvaliq is available in suspension;oral dosage forms.

The generics of Atorvaliq are possible to be released after 07 June, 2037.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11369567 CMP DEV LLC Aqueous suspension suitable for oral administration
Jun, 2037

(14 years from now)

Do you want to check out ATORVALIQ patents from before 2022?

Drugs and Companies using ATORVASTATIN CALCIUM ingredient

Market Authorisation Date: 01 February, 2023

Treatment: NA


More Information on Dosage

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in